Condition
Dermatologic Complication
Total Trials
5
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
25%
1 of 4 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 2 (1)
Trial Status
Completed4
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07442344Not ApplicableNot Yet Recruiting
Care Bundle for Prevention of Skin Complications and Edema in Restrained Patients
NCT05966779Completed
Physical Therapy in Lipedema Surgery
NCT04258904Not ApplicableCompleted
Prevention of Skin Problems With Diabetes Devices in Pediatric Patients
NCT04327752Completed
Skin Adverse Reactions Occuring in Children Treated by Biotherapy for Chronic Inflammatory Disease
NCT01867294Phase 2Completed
Spironolactone in Preventing Rash in Patients With Advanced Cancer Receiving Panitumumab and Cetuximab
Showing all 5 trials